Importantly, chemotherapeutic agents, such as doxorubicin, paclitaxel, and cisplatin activate TGF-β signaling to induce EMT and CSCs enrichment in human ovarian cancer and cervical cancer [13]. Here, TGFB1 is linked to ovarian cancer.